Imidazo[1,2-a]pyrazine-8-amine core for the design of human A3 and A2A adenosine receptor antagonists. Identification of new potent and selective adenosine A3 receptor antagonists. Pharmacological evaluation in an in vitro rat model of cerebral ischemia. Fluorescence emission property determination. Molecular docking analysis at our human A3 receptor model.